Protagonist Therapeutics Inc (PTGX)
Cash & Equivalents
$420.08M
Quarterly · Period ending: · USD
PTGX Cash & Equivalents
Latest reported$420.08Mperiod ending
Latest reported$420.08Mperiod ending
PTGX Quarterly Cash & Equivalents (-$9.32M → $420.08M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
PTGX cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 420,078,000 | |
| 193,712,000 | |
| 128,390,000 | |
| 113,713,000 | |
| 168,543,000 | |
| 139,653,000 | |
| 97,249,000 | |
| 131,121,000 | |
| 355,643,000 | |
| 172,568,000 | |
| 186,727,000 | |
| 230,527,000 | |
| 235,382,000 | |
| 127,686,000 | |
| 125,744,000 | |
| 152,816,000 | |
| 120,237,000 | |
| 98,477,000 | |
| 123,665,000 | |
| 120,542,000 | |
| 192,412,000 | |
| 83,000,000 | |
| 117,358,000 | |
| 83,625,000 | |
| 146,242,000 | |
| 60,215,000 | |
| 33,006,000 | |
| 50,195,000 | |
| 71,143,000 | |
| 70,077,000 | |
| 82,233,000 | |
| 87,427,000 | |
| 63,864,000 | |
| 69,577,000 | |
| 106,029,000 | |
| 50,395,000 | |
| 10,365,000 | |
| 9,517,000 | |
| 21,084,000 | |
| 96,024,000 | |
| 13,768,000 | |
| 28,629,000 | |
| 4,055,000 | |
| -9,324,000 |